Media Relations
Friday,
May 7,
2004
Biocomplexity
If "surgical manipulation of body parts . . . resurrection of life . . . the ethical consequences of engaging powers we've yet to morally know how to use" reads like a lead-in for a Halloween movie marathon then the public can expect much more next week when biologist David Stocum presents on the seasonally-timed topic of "The Legacy of Frankenstein: Regenerative Biology and Medicine."
Full Story >>
Research published by a team of Indiana University bioinformaticists has shown quantitatively the influence of small sequence changes and environmental conditions on the disordered regions of a protein.
Full Story >>
Indiana University's School of Informatics, founded in 2000 as the first school of its kind in the United States, has officially awarded its first PhD in informatics. The doctoral degree to James Costello was formally recorded by the university on August 31.
Full Story >>
A Biocomplexity Institute team led by Indiana University Bloomington biophysicist James Glazier with collaborators András Czirók, Randy Heiland, Charles Little, Herbert Sauro and Santiago Schnell is set to receive $2.7 million from the National Institutes of Health to expand studies of early animal development, addressing age-old problems in developmental biology.
Full Story >>
SpheroSense Technologies Inc. has entered into a licensing agreement with the Indiana University Research & Technology Corp. to develop market-ready biosensor technologies. SpheroSense has chosen a headquarters for its research and development activities on Bloomington's south side.
Full Story >>
A new company, SpheroSense Technologies Inc., founded by scientists at IU Bloomington, aims to become the leader in continuous-monitoring devices for research, medical and safety applications based on a new type of miniature optical device. Unlike most existing technologies, this biosensor can detect small molecules, drugs, proteins, viruses, DNA and RNA, and it can be manufactured inexpensively enough to be disposable after delivering results in minutes. The combination of flexibility, compact size, high-speed detection and low price will make the new biosensor ideal for clinical, laboratory and industrial applications, including in a physician's office.
Full Story >>
